News | Radiation Therapy | August 27, 2019

Offerings will include QA equipment for MR-guided and stereotactic therapy

Beamscan MR 3D water phantom – the first 3-D water phantom for magnetic resonance (MR)-guided radiotherapy

August 27, 2019 — Radiation dosimetry company PTW announced plans to exhibit its full range of radiation therapy dosimetry solutions for acceptance, commissioning, beam data acquisition and patient-specific quality assurance (QA) at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-19 in Chicago.

In its booth, PTW will exhibit and demonstrate its latest solutions and most recent product developments including:

  • Beamscan MR 3D water phantom – the first 3-D water phantom for magnetic resonance (MR)-guided radiotherapy, available in two ready-to-use models for Elekta Unity and ViewRay MRIdian;
  • Beamscan 3D water phantom – fast to set up and easy to use for all acceptance testing and commissioning needs, now also available for the Halcyon system;
  • Starcheck maxi MR array – a comprehensive solution for machine QA, from high-resolution measurements up to 40 cm x 40 cm in magnetic fields to legally required documentation;
  • MR-conditional detectors – a wide range of PTW's detector brands that are now available for MR dosimetry;
  • Octavius 4-D modular patient and machine QA systems – for the latest radiotherapy techniques, including Halcyon, stereotactic radiosurgery (SRS) and MRgRT. Also introducing the Octavius Detector 1600 SRS for 3-D dose verification of complex SRS/SBRT (stereotactic body radiation therapy) treatment plans;
  • Ruby phantom – a new modular QA phantom with multiple inserts for comprehensive system QA, linear accelerator (linac) QA and patient QA;
  • microSilicon diode detector – the new silicon diode detector for small photon and all electron fields; and
  • Track-it 2.0 QA data management software – a versatile, web-based QA data management software that integrates QA data from different sources, devices and sites into a single platform.

For more information: www.ptwdosimetry.com


Related Content

News | Interventional Radiology

Dec. 1, 2025 — GE HealthCare has unveiled the Allia Moveo,1 an image guiding solution designed to enhance mobility and ...

Time December 02, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
News | Lung Imaging

Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI ...

Time November 07, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Stereotactic Body Radiation Therapy (SBRT) | American Society for Radiation Oncology

Sept. 29, 2025 — A new clinical trial report finds that stereotactic radiation therapy offers long-term survival ...

Time October 15, 2025
arrow
Subscribe Now